Health
Brandon BioCatalyst secures $50m grant for new med-tech incubator tackling dementia
A national biotechnology incubator run by the venture capital-backe...
Vaxxas opens needle-free vaccine manufacturing HQ in Brisbane
Brisbane biotechnology company Vaxxas has opened the doors of ...
Brisbane medtech accelerator welcomes 2023 cohort
Spider venom to treat heart attack and stroke, technology to grow a...
Wesfarmers’ API acquires telehealth giant InstantScripts for $135m, Bailador Technology bags $52m
In a major move that will help scale its health division, Wesfarmer...
Telix Pharmaceuticals opens $21m nuclear medicine facility in Belgium
Australia’s second-largest biotechnology company by revenue b...
Advertisement
Latest News
AsheMorgan gains ministerial approval for $700m BTR project at Melbourne’s Docklands
Sydney-based private equity real estate group AsheMorgan has secure...
Centuria seals $70m deal for WA’s Halls Head Central at 40pc below replacement cost
Sydney-based property funds manager Centuria Capital Group (ASX: CN...
Australian horse gut health pioneer Poseidon enters US market
From its origins as a husband and wife applying their pharmaceutica...
Goulburn Valley glasshouse deal boosts Centuria Agriculture Fund's portfolio to $450m
Property fund manager Centuria Capital Group (ASX: CNI) has boosted...
Fast-growing AI-backed customer support platform Brainfish raises $3.85m
Sydney tech startup Brainfish, an AI-powered customer support platf...
Emyria partners with UWA on psychedelic therapy development
Clinic operator and alternative treatment company Emyria (ASX: EMD)...
"A necessity": Why WA's Cannaponics is going off the grid
As Cannaponics founder Rod Zakostelsky steers the Perth-based med...
Starpharma claims anti-COVID nasal spray proves its strength against Delta variant
Listed pharmaceutical company Starpharma (ASX: SPL) has today dou...
Australia's top 20 cannabis companies 2021
Investing in the medicinal cannabis industry is not for the faint-h...
Smiles Inclusive partners lose chance to claim $97m as Exit Solutions picks up final scraps
Unsecured creditors in formerly ASX-listed, failed Gold Coast-bas...
Atomo shares spike after FDA clears COVID-19 antibody test for sale in the US
Atomo Diagnostics (ASX: AT1) has cleared a major regulatory hurdl...
Ellume fast tracks US travel with rapid testing for Delta Airlines passengers
Brisbane-based diagnostics company Ellume has struck a major deal...
Starpharma shares plunge as UK sales paused over promotional claim concerns
Pharmaceutical company Starpharma (ASX: SPL) and its retail partn...
Vitamins subscription healthtech Vitable nourished by $5.5m Series A raise
A Sydney-based online platform for vitamin supplement subscriptio...
Are 3D-printed COVID tests the tip of the iceberg for Australian medical device manufacturing?
Australia's high labour costs have traditionally made it toug...
FDA rejuvenates Avita Medical burns treatment
Avita Medical Inc. (ASX: AVH) has received a big shot in the arm ...
Cogstate into gear as partners achieve breakthrough FDA approval for Alzheimer's drug
Investors in Melbourne-based digital cognitive assessment technol...
ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ
Earlier this year a Byron Bay-based company achieved a milestone ...
Could new findings put Mesoblast back in the COVID treatment race?
After four months in the doldrums due to its COVID-19 treatment i...
AnteoTech launches 15-minute COVID-19 test in Europe
Brisbane-based biotech firm AnteoTech (ASX: ADO) has officially l...
Advertisement
Partner Content
Beginning its life as a single store startup in Sydney’s tren...
'Digitisation' and 'digitalisation' are two words t...
With the ongoing supply chain crisis expected to continue throughou...
From COVID-19 restrictions changing the way people shop, to supply ...
Aon’s 2021 Global Risk Management Survey has revealed that lo...
"We didn't set out to build a BNPL platform. We set out to...
The last two years have delivered major disruption to the technolog...
If you are not reassessing how your organisation remunerates and re...
Advertisement